<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04970563</url>
  </required_header>
  <id_info>
    <org_study_id>21-12</org_study_id>
    <nct_id>NCT04970563</nct_id>
  </id_info>
  <brief_title>Detection of Asymptomatic SARS-Cov2 Infected Patients by Detection Dogs: &quot;Proof of Concept&quot; Study (CoviDetectionDog)-Covid-19</brief_title>
  <official_title>Detection of Asymptomatic SARS-Cov2 Infected Patients by Detection Dogs: &quot;Proof of Concept&quot; Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hôpital Européen Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hôpital Européen Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The spread of the new SARS-CoV-2 virus has led to a pandemic. Described for the first time in&#xD;
      China at the end of 2019, it causes Covid-19 disease. Its characteristics in terms of&#xD;
      contagiousness and lethality have led countries to adapt their screening and care strategies.&#xD;
&#xD;
      Early and accurate identification of people infected with SARs-CoV-2 is an essential measure&#xD;
      to confront Covid-19 pandemic. A key aspect of Covid-19 is that diagnostic tests must be able&#xD;
      to detect the virus in asymptomatic, pre-symptomatic and symptomatic patients.&#xD;
&#xD;
      Changes in human odor, as symptoms of specific diseases, have been observed. Dogs have&#xD;
      already been used to detect breast or lung cancer, diabetes, epilepsy or kidney disease with&#xD;
      some success There is currently a growing body of research and previous work, though&#xD;
      preliminary, indicating the possibility that dogs identify persons infected with Sars-Cov-2&#xD;
      compared to healthy persons.&#xD;
&#xD;
      The purpose of this study is to determine whether trained detection dogs are able to identify&#xD;
      asymptomatic patients infected by Sars-Cov-2.&#xD;
&#xD;
      The investigators aim to validate the possibility to identify / discriminate patients with&#xD;
      Covid-19 according to their odor by a proof of concept (with specificity and sensitivity of&#xD;
      the detection test), i.e. new non-invasive screening method using dogs odor detection&#xD;
      capabilities.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 21, 2021</start_date>
  <completion_date type="Anticipated">April 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage behavioral response of trained dogs obtained on sweat samples from patients infected by asymptomatic SARS-Cov-2.</measure>
    <time_frame>Six months</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Infection by SARS-COV-2</condition>
  <condition>Healthy Controls</condition>
  <arm_group>
    <arm_group_label>Patients infected by SARS-COV-2 (RT-PCR +) and asymptomatic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>&quot;Control&quot; group: patients infected by SARS-COV-2 (RT-PCR +) and symptomatic</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>&quot;Healthy controls&quot; group: not infected by SARS-COV-2 (RT-PCR-) and asymptomatic.</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Body odor samples</intervention_name>
    <description>Participants will provide six body odor samples (mask and sweat samples) at inclusion</description>
    <arm_group_label>&quot;Control&quot; group: patients infected by SARS-COV-2 (RT-PCR +) and symptomatic</arm_group_label>
    <arm_group_label>Patients infected by SARS-COV-2 (RT-PCR +) and asymptomatic</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Body odor samples</intervention_name>
    <description>Participants will provide six body odor samples (masks and compresses) at inclusion. A 7-day follow-up will be carried out to check, respectively, the absence of symptoms and the persistence of negativity on the SARS-COV-2 PCR test</description>
    <arm_group_label>&quot;Healthy controls&quot; group: not infected by SARS-COV-2 (RT-PCR-) and asymptomatic.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged ≥ 18 years&#xD;
&#xD;
          -  Having given free and informed written consent&#xD;
&#xD;
          -  Being affiliated to the center national security system social&#xD;
&#xD;
          -  Patients infected by SARS-COV-2 with positive RT PCR on nasopharyngeal swab and&#xD;
             without symptoms (fever, cough, anosmia, diarrhea) will be included in &quot;experimental&quot;&#xD;
             Group 1.&#xD;
&#xD;
          -  Patients infected by SARS COV 2 with positive RT PCR on nasopharyngeal swab and&#xD;
             presenting at least one symptom will be included in Group 2 &quot;control&quot;.&#xD;
&#xD;
          -  Participants not infected by SARS-COV-2 with negative RT PCR on nasopharyngeal sample&#xD;
             and showing no symptoms on Day 0 and Day 7 will be included in Group 3 &quot;healthy&#xD;
             controls&quot;.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Patient whose life expectancy is less than 3 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hôpital Européen Marseille</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Myriam BENNANI</last_name>
      <phone>04 13 42 83 51</phone>
      <email>m.bennani@hopital-europeen.fr</email>
    </contact>
    <investigator>
      <last_name>Frederique RETORNAZ, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 16, 2021</study_first_submitted>
  <study_first_submitted_qc>July 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2021</study_first_posted>
  <last_update_submitted>July 20, 2021</last_update_submitted>
  <last_update_submitted_qc>July 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

